Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region.
about
Artemisinin combination therapy for vivax malariaPrimaquine in vivax malaria: an update and review on management issuesPlasmodium vivax Landscape in Brazil: Scenario and ChallengesGlucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in Manaus: a cross-sectional survey in the Brazilian AmazonFunctional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparumUnderstanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literatureAssessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literatureChloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.Malaria in Brazil: an overview.Estimates of adherence to treatment of vivax malariaExpression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon.Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon.In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, IndonesiaIn vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central ChinaA new high-throughput method for simultaneous detection of drug resistance associated mutations in Plasmodium vivax dhfr, dhps and mdr1 genes.History, dynamics, and public health importance of malaria parasite resistance.Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region.Confirmed Plasmodium vivax Resistance to Chloroquine in Central VietnamChloroquine resistance in Plasmodium vivax.Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors.Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas.Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, EthiopiaIn vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian AmazonUse of a colorimetric (DELI) test for the evaluation of chemoresistance of Plasmodium falciparum and Plasmodium vivax to commonly used anti-plasmodial drugs in the Brazilian Amazon.Plasmodium vivax chloroquine resistance and anemia in the western Brazilian AmazonPlasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.Gancidin W, a potential low-toxicity antimalarial agent isolated from an endophytic Streptomyces SUK10Plasmodium vivax malaria elimination: should innovative ideas from the past be revisited?Malaria in the State of Amazonas: a typical Brazilian tropical disease influenced by waves of economic development.Description of a possible clonal expansion of Plasmodium vivax in Manaus-Amazonas-Brazil.Genetic diversity of chloroquine-resistant Plasmodium vivax parasites from the western Brazilian Amazon.Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malariaFactors associated with non-adherence to the treatment of vivax malaria in a rural community from the Brazilian Amazon Basin.Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.Assessment of chloroquine single dose treatment of malaria due to Plasmodium vivax in Brazilian Amazon.Characterisation of pvmdr1 and pvdhfr genes associated with chemoresistance in Brazilian Plasmodium vivax isolates.Border malaria associated with multidrug resistance on Thailand-Myanmar and Thailand-Cambodia borders: transmission dynamic, vulnerability, and surveillance.[Uncomplicated Plasmodium vivax and P. falciparum malaria in Brazil: evidence on single and combined drug treatments recommended by official guidelines].Administration of naloxone in combination with recombinant Plasmodium vivax AMA-1 in BALB/c mice induces mixed Th1/Th2 immune responses.
P2860
Q24622539-921951AD-29A2-4101-A1D0-E3C004157A4EQ27003856-80BE4574-280F-4200-80D9-7CA83C1D5C44Q28353930-9C4AE44D-9B17-4251-92BC-F7DA7DD63AE5Q28475311-9FD85DD3-E1F0-414D-B5AB-29ADB0F4318AQ28481173-07CEDCC9-7AD5-4802-B768-0708F92B246AQ33399080-20B68B47-8B1C-4562-A97A-2D08F1D6221FQ33577218-DC6AF556-ABAA-4F9A-8DC3-03E33828E32EQ33612286-8D57DEA9-6455-452B-AB29-E4537C1FFB0BQ33939774-045C3445-9180-4FE5-A3E4-5941785DA146Q34076554-C8F86ABD-97DD-4466-9683-ADF61F283441Q34089944-6FDADBE5-DAEB-4D7F-A466-72B330655B29Q34241857-887726A0-2005-4F52-A2DE-C52DD0A218C5Q34596770-09F355E9-63A1-49B0-8DB2-24191769B002Q35095652-EE05A234-4F52-4FB3-A389-27A537560386Q35131344-4C24A98F-EB62-4311-9AAD-FC9A9CA7EE8CQ35338795-F7F0E44C-F5E8-4DE4-ABF1-52D6954D6A34Q35545447-8831A941-E8B0-490F-9812-76168AE48CA2Q35728849-50C9CE70-5425-4105-810D-C91CA275699AQ35782842-2C4455C8-0A5F-472A-9BFD-9F5D665CBFE8Q35927662-C7AA60A2-09D0-49DF-8C25-AAF39043E74FQ36144322-D16B346B-AB0D-46F9-920F-AB0BBF65CE2DQ36592120-B056AF06-BDE8-4194-98AF-4FC99F3EB0BCQ36975316-7E4AA975-782C-4D59-BB83-C6C26BD82E6DQ36992900-30A2D0B9-C24F-4273-A0BA-480DB8D58566Q37153232-E92DC533-0DEB-4719-9D28-9122FE37D43CQ37544412-B02F1868-DFE4-45F5-AFFB-359E1098CAD8Q37623460-6070C2CC-B41F-4842-910E-EF9DD73528ABQ37641492-925373C7-52A1-4E8B-896A-3A9D14564BABQ38245791-817AAB60-07CE-4B05-AC1A-C5ACC223A5F9Q38523698-43A0A83A-CFF5-4D4B-897A-A7CD5F6C4C2DQ38867982-128C0BB1-7215-4571-9F00-978991CB1553Q39185811-2C625C06-58B9-441F-A8C9-D31984DB2A87Q39543705-B83AF8C6-D7E9-4CBF-B1E0-D985F74841F0Q39756399-2507F811-A13A-47C9-ABCB-9B4BD0B6609EQ40081673-45BF6055-0DA1-4DCE-ABCF-BFAEFC215559Q41914575-5E0529D4-E052-42FB-BB3C-BE4D47F51036Q41937010-A75A3B56-EA2D-4E40-88F0-7FF86468A957Q42181962-0B2BA08A-4AA4-4368-B7E2-ECE890D5A4B4Q47844914-E93B8FDF-DEF1-45DE-BB92-0EB59DE3F6C6Q47923410-8BE5D2E9-C2B8-42F1-B44D-5E97CCA00550
P2860
Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Plasmodium vivax resistance to ...... 3) in Brazilian Amazon region.
@en
type
label
Plasmodium vivax resistance to ...... 3) in Brazilian Amazon region.
@en
prefLabel
Plasmodium vivax resistance to ...... 3) in Brazilian Amazon region.
@en
P2093
P2860
P1476
Plasmodium vivax resistance to ...... 3) in Brazilian Amazon region.
@en
P2093
Alecrim M das G
P2860
P356
10.1590/S0037-86821999000100013
P577
1999-01-01T00:00:00Z